Acid build-up in the blood
Every manufacturer places this the same way.
scroll for all 10 products →
| Section | Strides Pharma UK Ltd50mg Tablets | Aurobindo Pharma - Milpharm Ltd.50mg Tablets | Ipca Laboratories UK Ltd50mg Tablets | Medley Pharma Limited50mg Tablets | SyriMed5mg Oral Solution | Rosemont Pharmaceuticals Limited25mg/5ml Oral Solution | Wockhardt UK Ltd25mg Tablets | Wockhardt UK Ltd12.5mg Tablets | Atnahs Pharma UK Ltd100mg Tablets | Atnahs Pharma UK Ltd50mg Tablets |
|---|---|---|---|---|---|---|---|---|---|---|
| ContraindicatedThe label says it must not be used. | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated |
| WarningThe label says it can be used, with care. | ||||||||||
| InteractionThe label says another medicine affects it. | ||||||||||
| PregnancyThe label gives advice for pregnancy or breastfeeding. | ||||||||||
| ExcipientThe label lists it as an ingredient, not a restriction. |
- Contraindicated
Aurobindo Pharma - Milpharm Ltd.
Source SmPC ↗345–363 of 463 characters Source SmPC ↗345–363 of 463 characters Source SmPC ↗330–348 of 437 characters Rosemont Pharmaceuticals Limited
Source SmPC ↗343–361 of 460 characters Source SmPC ↗253–271 of 550 characters Source SmPC ↗252–270 of 548 characters Source SmPC ↗345–363 of 463 characters Source SmPC ↗345–363 of 463 characters
to any of the excipients listed in section 6.1 • cardiogenic shock • uncontrolled heart failure • sick sinus syndrome • second-or third-degree heart block • untreated phaeochromocytoma • metabolic acidosis • bradycardia (<45 bpm) • hypotension • severe peripheral arterial circulatory disturbances.
Identical in all 8 labels. Surrounding text shown from Aurobindo Pharma - Milpharm Ltd..
- Contraindicated
Source SmPC ↗449–468 of 485 characters
• bradycardia (<45 bpm). • Uncontrolled heart failure. • cardiogenic shock. • sick sinus syndrome. • untreated phaeochromocytoma. • severe peripheral arterial circulatory disturbances. • metabolic acidosis. • hypotension.
- Contraindicated
Source SmPC ↗373–391 of 654 characters
ed in section 6.1. - Second or third-degree heart block. - Cardiogenic shock. - Uncontrolled heart failure. - Sick sinus syndrome (including sino-atrial block). - Untreated phaeochromocytoma. - Metabolic acidosis - Bradycardia (less than 45-50 beats per minute) - Hypotension - Severe peripheral circulatory disturbances - Concomitant intravenous use of verapamil or diltiazem - Severe asthma and severe chr